<DOC>
	<DOC>NCT02664207</DOC>
	<brief_summary>The purpose of this study is to offer pre-natal Myelomeningocele (MMC) repair surgery to mothers with a BMI of 35-40 kg/m2 (extending the Management of Myelomeningocele Study (MOMs) criteria for BMI) and to evaluate the efficacy and safety of this extension, by capturing clinical and outcome information.</brief_summary>
	<brief_title>Extended Criteria For Fetal Myelomeningocele Repair</brief_title>
	<detailed_description />
	<mesh_term>Meningomyelocele</mesh_term>
	<mesh_term>Spina Bifida Cystica</mesh_term>
	<criteria>Any woman with a prenatal diagnoses of myelomeningocele. Prepregnancy BMI of 3540 kg/m2. same MOMs Trial inclusion criteria (with the exception of BMI) poor glycemic control (i.e., HbA1c â‰¥ 8%) in spite a medical antidiabetic therapy in accordance with good clinical practice (GCP) presence of significant comorbidities or complications (such as dyslipidemia, uncontrolled arterial hypertension, impaired renal function, neuropathy, retinopathy, CVD) severe diabetes complications or associated medical conditions (such as blindness, endstage renal failure, liver cirrhosis, malignancy, chronic congestive heart failure) recent (within preceding 12 months) myocardial infarction, stroke or TIA unstable angina pectoris same MOMs Trial exclusion criteria (with the exception of BMI)</criteria>
	<gender>Female</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>Myelomeningocele repair</keyword>
	<keyword>Open Neural Tube Defect</keyword>
	<keyword>BMI of 35-40 kg/m2,</keyword>
	<keyword>Open Fetal Surgery</keyword>
	<keyword>Elevated body mass index</keyword>
</DOC>